Observational studyJournal for immunotherapy of cancer2024

Safety and tolerability of immune checkpoint inhibitors in people with HIV infection and cancer: insights from the national prospective real-world OncoVIHAC ANRS CO24 cohort study.

Lambert Assoumou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.